p53 expression in colorectal cancer may thus serve as a prognostic tool, aiding in the identification of patients at a higher risk of adverse disease progression, allowing for more accurate treatment planning and potentially earlier application of more aggressive interventions [118]. The gene discussed is TP53; the disease is colorectal cancer.